(Q42809859)

7 November 2017

Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides (English)

1 reference

7 November 2017

Hyunmin Kang

1

1 reference

7 November 2017

Robert DeLong

series ordinal

2

1 reference

7 November 2017

Michael H Fisher

series ordinal

3

1 reference

7 November 2017

Rudolph L Juliano

series ordinal

4

1 reference

7 November 2017

1 October 2005

1 reference

7 November 2017

Pharmaceutical Research

1 reference

7 November 2017

22

1 reference

7 November 2017

12

1 reference

7 November 2017

2099-2106

1 reference

Aspects of the transport and delivery of antisense oligonucleotides.

7 November 2017

1 reference

12 December 2020

Progress in antisense technology.

1 reference

12 December 2020

Strategies for inhibition of MDR1 gene expression.

1 reference

12 December 2020

Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications

1 reference

12 December 2020

siRNAs: applications in functional genomics and potential as therapeutics

1 reference

12 December 2020

Dendrimer-based nanosized MRI contrast agents

1 reference

12 December 2020

A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.

1 reference

12 December 2020

Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA.

1 reference

12 December 2020

Cell penetrating peptides in drug delivery

1 reference

12 December 2020

Membrane-permeable arginine-rich peptides and the translocation mechanisms

1 reference

12 December 2020

Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents.

1 reference

12 December 2020

Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.

1 reference

12 December 2020

Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity

1 reference

12 December 2020

Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo

1 reference

12 December 2020

Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates

1 reference

12 December 2020

P-glycoprotein: from genomics to mechanism.

1 reference

12 December 2020

PAMAM dendrimers as delivery agents for antisense oligonucleotides

1 reference

12 December 2020

Oligonucleotide conjugates as potential antisense drugs with improved uptake, biodistribution, targeted delivery, and mechanism of action

1 reference

12 December 2020

A new vector using the human multidrug resistance gene as a selectable marker enables overexpression of foreign genes in eukaryotic cells

1 reference

12 December 2020

Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation

1 reference

12 December 2020

Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles.

1 reference

12 December 2020

Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery

1 reference

12 December 2020

Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression

1 reference

12 December 2020

Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers

1 reference

12 December 2020

10.1007/S11095-005-8330-5

Identifiers

DOI

1 reference

7 November 2017

1 reference